Industry
Biotechnology
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Loading...
Open
1.22
Mkt cap
77M
Volume
469K
High
1.30
P/E Ratio
-0.53
52-wk high
4.65
Low
1.11
Div yield
N/A
52-wk low
1.11
Portfolio Pulse from Benzinga Newsdesk
October 23, 2024 | 9:45 am
Portfolio Pulse from Benzinga Newsdesk
October 22, 2024 | 11:00 am
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 1:30 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 12:56 pm
Portfolio Pulse from Benzinga Newsdesk
August 07, 2024 | 8:47 pm
Portfolio Pulse from Benzinga Newsdesk
May 14, 2024 | 5:23 pm
Portfolio Pulse from Benzinga Insights
May 14, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 14, 2024 | 4:07 pm
Portfolio Pulse from Benzinga Newsdesk
May 14, 2024 | 12:27 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.